LIPID-LOWERING EFFECT OF BEZAFIBRATE IN PATIENTS WITH DIABETES-MELLITUS AND HYPERLIPEMIA

被引：17

作者：

WAHL, P ^{[1
]}

HASSLACHER, C ^{[1
]}

LANG, PD ^{[1
]}

VOLLMAR, J ^{[1
]}

机构：

[1] BOEHRINGER MANNHEIM GMBH, D-6800 MANNHEIM, FED REP GER

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1978年 / 103卷 / 31期

关键词：

D O I：

10.1055/s-0028-1129237

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1233 / 1237

页数：5

共 34 条

[1] CIRCULATING LIPIDS IN DIABETES MELLITUS [J].

ADLERSBERG, D ;

EISLER, L .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1959, 170 (11) :1261-1265

[2] VASCULAR DISEASE AND SERUM LIPIDS IN DIABETES MELLITUS - OBSERVATIONS OVER 30 YEARS (1931-1961) [J].

ALBRINK, MJ ;

LAVIETES, PH ;

MAN, EB .

ANNALS OF INTERNAL MEDICINE, 1963, 58 (02) :305-+

[3]

BERGQVIST N, 1970, ACTA MED SCAND, V187, P213

[4]

BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891

[5] A TEST FOR SYMMETRY IN CONTINGENCY TABLES [J].

BOWKER, AH .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1948, 43 (244) :572-574

[6]

BRADLEY J. V., 1968, DISTRIBUTION FREE ST

[7]

BRUNS W, 1974, ENDOKRINOLOGIE, V64, P1

[8]

DAUBRESSE JC, 1976, NEW ENGL J MED, V294, P613

[9]

ENDELE R, IN PRESS

[10]

ENGER SC, 1977, ACTA MED SCAND, V201, P563

← 1 2 3 4 →